Lupus Nephritis.
D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000209:etiology; D000818:Animals; D005260:Female; D005455:Fluorescent Antibody Technique; D005921:Glomerulonephritis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D006801:Humans; D007105:Immune Complex Diseases / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000628:therapy; D007678:Kidney Glomerulus / Q000648:ultrastructure; D016030:Kidney Transplantation; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D051379:Mice; D008875:Middle Aged; D009393:Nephritis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D009395:Nephritis, Interstitial / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D009404:Nephrotic Syndrome / Q000209:etiology; D011379:Prognosis
D007166:Immunosuppressive Agents